Search

Shobha Kantamneni

Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )

Most Active Art Unit
1627
Art Unit(s)
1627, 1617, 1623
Total Applications
1212
Issued Applications
306
Pending Applications
120
Abandoned Applications
793

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6912933 [patent_doc_number] => 20050176691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Combination therapy for the treatment of estrogen-sensitive disease' [patent_app_type] => utility [patent_app_number] => 10/982697 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11972 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176691.pdf [firstpage_image] =>[orig_patent_app_number] => 10982697 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/982697
Combination therapy for the treatment of estrogen-sensitive disease Nov 4, 2004 Abandoned
Array ( [id] => 7098486 [patent_doc_number] => 20050130945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Combination therapy for the treatment of estrogen-sensitive disease' [patent_app_type] => utility [patent_app_number] => 10/982533 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11967 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130945.pdf [firstpage_image] =>[orig_patent_app_number] => 10982533 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/982533
Combination therapy for the treatment of estrogen-sensitive disease Nov 4, 2004 Abandoned
Array ( [id] => 7127976 [patent_doc_number] => 20050059720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Medicinal compositions for the prevention or treatment of cardiac failure' [patent_app_type] => utility [patent_app_number] => 10/977645 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6348 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059720.pdf [firstpage_image] =>[orig_patent_app_number] => 10977645 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977645
Medicinal compositions for the prevention or treatment of cardiac failure Oct 28, 2004 Abandoned
Array ( [id] => 7127921 [patent_doc_number] => 20050059665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/969079 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41735 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059665.pdf [firstpage_image] =>[orig_patent_app_number] => 10969079 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/969079
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use Oct 20, 2004 Abandoned
Array ( [id] => 7181338 [patent_doc_number] => 20050124685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning' [patent_app_type] => utility [patent_app_number] => 10/945241 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10283 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124685.pdf [firstpage_image] =>[orig_patent_app_number] => 10945241 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/945241
Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning Sep 19, 2004 Abandoned
Array ( [id] => 5068969 [patent_doc_number] => 20070190070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/590575 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25249 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190070.pdf [firstpage_image] =>[orig_patent_app_number] => 10590575 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/590575
Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system Sep 2, 2004 Abandoned
Array ( [id] => 7238337 [patent_doc_number] => 20050080100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Pyridylamino compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/926493 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5528 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080100.pdf [firstpage_image] =>[orig_patent_app_number] => 10926493 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/926493
Pyridylamino compounds and methods of use thereof Aug 25, 2004 Abandoned
Array ( [id] => 7060619 [patent_doc_number] => 20050002979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Method of treating actinic keratosis' [patent_app_type] => utility [patent_app_number] => 10/900279 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5464 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002979.pdf [firstpage_image] =>[orig_patent_app_number] => 10900279 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/900279
Method of treating actinic keratosis Jul 27, 2004 Abandoned
Array ( [id] => 7352331 [patent_doc_number] => 20040248977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Rapid growth dairy heifers having reduced mammary fat content' [patent_app_type] => new [patent_app_number] => 10/486751 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3567 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248977.pdf [firstpage_image] =>[orig_patent_app_number] => 10486751 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/486751
Rapid growth dairy heifers having reduced mammary fat content Jul 25, 2004 Abandoned
Array ( [id] => 7352200 [patent_doc_number] => 20040248948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Combination therapy' [patent_app_type] => new [patent_app_number] => 10/879937 [patent_app_country] => US [patent_app_date] => 2004-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13141 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248948.pdf [firstpage_image] =>[orig_patent_app_number] => 10879937 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/879937
Combination therapy Jun 28, 2004 Abandoned
Array ( [id] => 5733633 [patent_doc_number] => 20060258750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/562393 [patent_app_country] => US [patent_app_date] => 2004-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3769 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258750.pdf [firstpage_image] =>[orig_patent_app_number] => 10562393 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/562393
Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions Jun 21, 2004 Abandoned
Array ( [id] => 7089641 [patent_doc_number] => 20050009754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Use of growth hormone secretagogues for treatment of fibromyalgia' [patent_app_type] => utility [patent_app_number] => 10/864667 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15627 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009754.pdf [firstpage_image] =>[orig_patent_app_number] => 10864667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/864667
Use of growth hormone secretagogues for treatment of fibromyalgia Jun 8, 2004 Abandoned
Array ( [id] => 7319266 [patent_doc_number] => 20040224989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'S-lansoprazole compositions and methods' [patent_app_type] => new [patent_app_number] => 10/863532 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3572 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224989.pdf [firstpage_image] =>[orig_patent_app_number] => 10863532 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/863532
S-lansoprazole compositions and methods Jun 7, 2004 Abandoned
Array ( [id] => 7122902 [patent_doc_number] => 20050014731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds' [patent_app_type] => utility [patent_app_number] => 10/855944 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3310 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014731.pdf [firstpage_image] =>[orig_patent_app_number] => 10855944 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855944
Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds May 27, 2004 Abandoned
Array ( [id] => 7122906 [patent_doc_number] => 20050014735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Treatment of Th2 dominated immunological disease states with progesterone receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/855790 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3204 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014735.pdf [firstpage_image] =>[orig_patent_app_number] => 10855790 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855790
Treatment of Th2 dominated immunological disease states with progesterone receptor antagonists May 27, 2004 Abandoned
Array ( [id] => 7155727 [patent_doc_number] => 20050026811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Rage antagonists as agents to reverse amyloidosis and diseases associated therewith' [patent_app_type] => utility [patent_app_number] => 10/850238 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21275 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026811.pdf [firstpage_image] =>[orig_patent_app_number] => 10850238 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/850238
Rage antagonists as agents to reverse amyloidosis and diseases associated therewith May 19, 2004 Abandoned
Array ( [id] => 10089131 [patent_doc_number] => 09125939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Carbostyril derivatives and mood stabilizers for treating mood disorders' [patent_app_type] => utility [patent_app_number] => 10/556600 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12883 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10556600 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556600
Carbostyril derivatives and mood stabilizers for treating mood disorders May 18, 2004 Issued
Array ( [id] => 7319347 [patent_doc_number] => 20040225017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Chloramine T based teat cleaner and related process' [patent_app_type] => new [patent_app_number] => 10/833431 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2621 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20040225017.pdf [firstpage_image] =>[orig_patent_app_number] => 10833431 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/833431
Chloramine T based teat cleaner and related process Apr 27, 2004 Issued
Array ( [id] => 7188759 [patent_doc_number] => 20050192356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Synergistic anti-inflammatory pharmaceutical compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/789814 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11200 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192356.pdf [firstpage_image] =>[orig_patent_app_number] => 10789814 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/789814
Synergistic anti-inflammatory pharmaceutical compositions and methods of use Feb 26, 2004 Abandoned
Array ( [id] => 6991490 [patent_doc_number] => 20050090527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis' [patent_app_type] => utility [patent_app_number] => 10/764780 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13424 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090527.pdf [firstpage_image] =>[orig_patent_app_number] => 10764780 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/764780
Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis Jan 25, 2004 Abandoned
Menu